Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
NCT: NCT06283524 · COMPLETED
Brief Summary
The overarching goal of this research protocol is to acquire eye-tracking, cognitive, and disease-severity metrics in MS patients to train machine learning algorithms that will support the development and performance assessment of a sensitive and non-invasive eye-tracking software application. The training of our machine learning classifying algorithms to identify which eye-tracking metrics-or combination thereof-can serve as reliable markers of MS disease severity and cognitive status.
Frequently Asked Questions
What is Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis?
Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis is a clinical trial registered under NCT06283524. Current status: COMPLETED.
What is the status of NCT06283524?
The current status of NCT06283524 (Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis) is: COMPLETED.
When did Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis start?
Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis started on 2024-03-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.